Cancer Incidence Among Users of Glucagon-Like Peptide-1 Receptor Agonists - Quiz - MDSpire

Cancer Incidence Among Users of Glucagon-Like Peptide-1 Receptor Agonists

  • By

  • Zayed Rashid

  • Selamawit Woldesenbet

  • Mujtaba Khalil

  • Abdullah Altaf

  • Shahzaib Zindani

  • Areesh Mevawalla

  • Azza Sarfraz

  • Khalid Mumtaz

  • Timothy M. Pawlik

  • February 26, 2026

  • 0 min

Share

Original Source(s)

Cancer Incidence Among Users of Glucagon-Like Peptide-1 Receptor Agonists

  • by Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil, Abdullah Altaf, Shahzaib Zindani, Areesh Mevawalla, Azza Sarfraz, Khalid Mumtaz, Timothy M. Pawlik

  • February 26, 2026

Related Content

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study

Waist-to-height ratio for OSA risk: a comparative analysis of NHANES and a clinical data

Reorienting catch-up growth research toward early-life prevention of metabolic disorders using natural products